Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Doxorubicin hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Doxorubicin (liposomal) 50mg inf vials
0801020K0AAAHAH
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 10mg powder for solution for injection vials
0801020K0AAAAAA
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 10mg/2ml solution for injection vials
0801020K0AAAIAI
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 10mg/5ml solution for injection vials
0801020K0AAACAC
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 200mg/100ml solution for infusion vials
0801020K0AAAJAJ
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 50mg powder for solution for injection vials
0801020K0AAABAB
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 50mg/25ml solution for injection vials
0801020K0AAADAD
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin pegylated liposomal 20mg/10ml inf vials
0801020K0AAAFAF
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin pegylated liposomal 50mg/25ml inf vials
0801020K0AAAGAG
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.